Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 6/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | MAPT | P10636 | 2/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 8/20 | 0.44 |
| ▸ | GPR35 | Q9HC97 | 3/20 | 0.43 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.41 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.41 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.41 |
| ▸ | GRIA2 | P42262 | 1/20 | 0.41 |
| ▸ | GRIA3 | P42263 | 1/20 | 0.41 |
| ▸ | GRIA4 | P48058 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4973651 | 0.83 | GPR35 (0.55) | TDP1ALDH1A1MAPTMEN1KMT2A | |
| SCHEMBL8415102 | 0.83 | TSHR (0.51) | TDP1CYP3A4ALDH1A1TSHRGPR35 | |
| SCHEMBL1758439 | 0.83 | ALDH1A1 (0.48) | TDP1CYP3A4ALDH1A1MAPTMEN1 | |
| SCHEMBL8415105 | 0.83 | TSHR (0.50) | TDP1CYP3A4ALDH1A1MAPTTSHR | |
| SCHEMBL11804756 | 0.83 | ALDH1A1 (0.58) | TDP1CYP3A4ALDH1A1MAPTALOX15 | |
| SCHEMBL11793674 | 0.83 | ALDH1A1 (0.44) | CYP3A4ALDH1A1MAPTTSHRGPR35 | |
| SCHEMBL11799394 | 0.83 | GPR35 (0.50) | TDP1CYP3A4ALDH1A1MAPTMEN1 | |
| SCHEMBL3366890 | 0.83 | ALDH1A1 (0.47) | TDP1CYP3A4ALDH1A1MAPTMEN1 | |
| SCHEMBL3366894 | 0.81 | ALDH1A1 (0.50) | TDP1CYP3A4ALDH1A1MAPTMEN1 | |
| SCHEMBL8688932 | 0.81 | TSHR (0.55) | TDP1CYP3A4ALDH1A1MAPTMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119136667-A | Ready-to-use plant treatment agent applicators, containers, and products | UPL有限责任公司 | 2024-12-13 | — | — | CN | disclosed |
| US-9828413-B2 | Vancomycin derivative, and preparation method and application thereof | ACESYS PHARMA INC. (CN) | 2017-11-28 | — | — | US | disclosed |
| US-9828413-B2 | Vancomycin derivative, and preparation method and application thereof | ACESYS PHARMA INC. (CN) | 2017-11-28 | — | — | US | disclosed |
| US-20160200768-A1 | VANCOMYCIN DERIVATIVE, AND PREPARATION METHOD AND APPLICATION THEREOF | ACESYS PHARMA INC. (CN) | 2016-07-14 | — | — | US | disclosed |
| US-20160200768-A1 | VANCOMYCIN DERIVATIVE, AND PREPARATION METHOD AND APPLICATION THEREOF | ACESYS PHARMA INC. (CN) | 2016-07-14 | — | — | US | disclosed |
| EP-3037431-A1 | VANCOMYCIN DERIVATIVE, AND PREPARATION METHOD AND APPLICATION THEREOF | Acesys Pharma Inc. (CN) | 2016-06-29 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160200768-A1 | VANCOMYCIN DERIVATIVE, AND PREPARATION METHOD AND APPLICATION THEREOF | LIPA, HDLBP, CETP | TDP1 4624/4885CYP3A4 221/4885ALDH1A1 2133/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.